Related Experiment Video
Updated: Jun 13, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
1Department of Neurology, CN Center, AIIMS, Ansari Nagar, New Delhi, India.
Abstract:
Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trials, on different antiplatelet regimes and the risk assessment that may be unique to each patient.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease V: Interprofessional Care